Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07441070 · ClinicalTrials.gov registry record · NA

Effect of Ashwagandha Root Extract on Stress, Anxiety, and Sleep Quality in Adults Experiencing Minority Stress

A NA study, sponsored by SF Research Institute.

Recruiting
Registry status
NA
Development phase
80
Enrollment target

NCT07441070 is a NA study that is actively recruiting participants, run by SF Research Institute. The registered enrollment target is 80 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07441070, a NA study, is actively recruiting participants, sponsored by SF Research Institute.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target

Study Summary

Sexual and gender minority adults often experience elevated levels of chronic stress due to stigma, discrimination, and social adversity, commonly referred to as minority stress. This persistent stress is associated with increased anxiety, mood disturbances, impaired sleep quality, and reduced quality of life. There is a need for safe, non-pharmacological interventions that can support mental well-being in this population. This randomized, double-blind, placebo-controlled study is designed to evaluate the efficacy and safety of Ashwagandha (Withania somnifera) root extract in reducing stress and improving anxiety and sleep quality in adults experiencing minority stress. A total of 80 adults aged 18 to 45 years who self-identify as sexual or gender minorities and report moderate to high perceived stress will be enrolled. Participants will be randomly assigned to receive either Ashwagandha root extract (300 mg capsules taken twice daily) or an identical placebo for 8 weeks. Efficacy will be assessed using validated psychological and quality-of-life questionnaires, including the Perceived Stress Scale, Depression Anxiety Stress Scale, Pittsburgh Sleep Quality Index, and other mood and minority stress measures. Salivary cortisol will be measured as a biological marker of stress. Safety will be evaluated through monitoring of adverse events throughout the study.

Interventions

  • OTHER Placebo Capsule
  • DIETARY_SUPPLEMENT Ashwagandha Root Extract

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2026-04-29
Est. Completion 2026-08-15
Phase NA

Sponsor

SF Research Institute

16 total trials

What the Registry Record Tells You About NCT07441070

The ClinicalTrials.gov registry entry for NCT07441070 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SF Research Institute, which has 16 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Placebo Capsule is the first listed.

NCT07441070 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07441070 about?

NCT07441070 is a clinical study titled "Effect of Ashwagandha Root Extract on Stress, Anxiety, and Sleep Quality in Adults Experiencing Minority Stress". Sexual and gender minority adults often experience elevated levels of chronic stress due to stigma, discrimination, and social adversity, commonly referred to as minority stress. This persistent stress is associated with increased anxiety, mood disturbances, impaired sleep quality, and reduced quali...

What is the current status of trial NCT07441070?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2026-04-29. Estimated completion is 2026-08-15.

What interventions are being tested in trial NCT07441070?

The interventions under investigation include: Placebo Capsule (OTHER), Ashwagandha Root Extract (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT07441070?

This trial is sponsored by SF Research Institute, which has 16 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.